PaxMedica's Research on Low Dose Suramin for Autism
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...
Stay updated with breaking news from Constance Smith Hicks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited to...
TARRYTOWN, N.Y. , Oct. 26, 2023 -- via IBN -- PaxMedica, Inc. a clinical-stage biopharmaceutical company, is excited to announce that the Annals of General Psychiatry, an internationally...
This week, Project BLANK, Bodhi Tree Concerts, 'Banksyland' and more
Share this article Share this article NEW YORK, Feb. 2, 2021 /PRNewswire/ -- The SynGAP Research Fund (SRF) announces a grant award to Dr. Thomas Frazier, Professor of Psychology at John Carroll University. Dr. Frazier will receive funding over two years for development and validation of a Neurobehavioral Evaluation Tool (NET) for autism and related genetic syndromes. The grant will facilitate the participation of SYNGAP1 patients and their caregivers in the development and application of the tool. SYNGAP1-related intellectual disability is a rare genetic disorder caused by a variation on t...